Analysis of cell polarity formation by gene transfection in organs in situ
器官原位基因转染细胞极性形成分析
基本信息
- 批准号:10470003
- 负责人:
- 金额:$ 8.13万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:1998
- 资助国家:日本
- 起止时间:1998 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
In vivo electroporation and particle gun methods were used to introduce exogenous genes into tissue cells in situ in living animals. Constructs of green fluorescent proteins were tested to optimize the conditions of gene transfection. Glucose transporters (GLUT1, GLUT3, GLUT4, GLUT5, and SGLT1) were introduced into cells of liver and pancreas of living rats. The expressed gene products were visualized by immunofluorescence staining of tissue sections. By optimizing the conditions of transfection, glucose transporters were successfully expressed in highly differentiated cells such as hepatocytes and pancreatic acinar cells forming tissues in situ. GLUT1 was localized to basolateral membrane domains in both hepatocytes and pancreatic acinar cells. GLUT3 and GLUT5 were restricted to apical membrane domain in pancreatic acinar cells. They were found in both the apical and basolateral domains in hepatocytes. These observations suggest differential targeting mechanism in hepatocytes and acinar cells : i.e., apical targeting is carried out by direct pathway in acinar cells, whereas it is mediated by the indirect transcytotic pathway in hepatocytes. GLUT4 was retained in the cytoplasmic compartments in both cell types. Immuno-electron microscopy revealed that GLUT4 resides in the membranes of zymogne secretary granules in acinar cells, showing that GLUT4 is sorted to the regulated secretion pathway in these cells. In addition, in vivo electroporation and particle gun methods are simple and versatile methods to study the localization of exogenous gene products in cells and tissues in situ.
采用体内电穿孔法和粒子枪法将外源基因原位导入活体动物的组织细胞中。构建绿色荧光蛋白,优化基因转染条件。将葡萄糖转运蛋白(GLUT 1、GLUT 3、GLUT 4、GLUT 5和SGLT 1)导入活体大鼠的肝脏和胰腺细胞。表达的基因产物通过组织切片的免疫荧光染色来可视化。通过优化转染条件,葡萄糖转运蛋白成功地在高分化细胞如肝细胞和胰腺腺泡细胞中原位表达。GLUT1定位于肝细胞和胰腺腺泡细胞的基底外侧膜域。GLUT3和GLUT5在胰腺腺泡细胞中局限于顶膜结构域。它们在肝细胞的顶侧和基底侧域都有发现。这些观察结果表明肝细胞和腺泡细胞中的差异靶向机制:即,顶端靶向在腺泡细胞中通过直接途径进行,而在肝细胞中通过间接转胞途径介导。GLUT 4保留在两种细胞类型的细胞质区室中。免疫电子显微镜显示,GLUT 4驻留在腺泡细胞中的酶原分泌颗粒的膜上,表明GLUT 4在这些细胞中被分选到受调节的分泌途径。此外,体内电穿孔和粒子枪方法是研究外源基因产物在细胞和组织中原位定位的简单而通用的方法。
项目成果
期刊论文数量(56)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kanno T: "NMDA-receptor-dependent and -independent cytotoxic effect of D. discoideum differentiation-inducing factor on rat cortical neurons"Develop Growth Differ. 43. 709-716 (2001)
Kanno T:“盘状 D. discoideum 分化诱导因子对大鼠皮质神经元的 NMDA 受体依赖性和非依赖性细胞毒性作用”发育生长差异。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sugawara-Yokoo M: "Differential localization of organic cation transporters rOCT1 and rOCT2 in the basolateral membrane of rat kidney tubules"Histochem Cell Biol. 114. 175-180 (2000)
Sugara-Yokoo M:“有机阳离子转运蛋白 rOCT1 和 rOCT2 在大鼠肾小管基底外侧膜中的差异定位”Histochem Cell Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Suzuki T: "The apical localization of SG1t1 glucose transporter is determined by the short amino acid sequence in its N-terminal domain"Eur J Cell Biol. 80. 765-774 (2001)
Suzuki T:“SG1t1 葡萄糖转运蛋白的顶端定位是由其 N 末端结构域中的短氨基酸序列决定的”Eur J Cell Biol。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takata K: "Sugar transporters in polarized epithelial cells." Acta Histochem Cytochem. (in press).
Takata K:“极化上皮细胞中的糖转运蛋白。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Kanno T.: "NMDA-receptor-dependent and -independent cytotoxic effect of D.discoideum differentlation-inducing factor on rat cortical neurons"Develop Growth Differ. 43. 709-716 (2001)
Kanno T.:“盘状 D.discoideum 分化诱导因子对大鼠皮质神经元的 NMDA 受体依赖性和非依赖性细胞毒性作用”发育生长差异。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKATA Kuniaki其他文献
TAKATA Kuniaki的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKATA Kuniaki', 18)}}的其他基金
Analysis of endosome/post-endosome system with special reference to water channel aquaporin 2
特别参考水通道水通道蛋白 2 的内体/内体后系统分析
- 批准号:
18390057 - 财政年份:2006
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular and cellular morphological analysis of sugar transporter dynamics between cell membrane and organelles
细胞膜和细胞器之间糖转运蛋白动力学的分子和细胞形态学分析
- 批准号:
15390053 - 财政年份:2003
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Development of immunohistochemistry using confocal microscopy and microinjection method
使用共聚焦显微镜和显微注射方法开发免疫组织化学
- 批准号:
09557002 - 财政年份:1997
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
Morphological studies on the transfer machinery molecules in the blood-tissue barriers.
血液组织屏障中转移机械分子的形态学研究。
- 批准号:
07457002 - 财政年份:1995
- 资助金额:
$ 8.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer
不可逆电穿孔 (IRE) 联合 CD40 激动作为胰腺癌原位疫苗治疗
- 批准号:
10718057 - 财政年份:2023
- 资助金额:
$ 8.13万 - 项目类别:
Academic-Industrial Partnership to Develop Clinical Tools for Algorithmic Irreversible Electroporation of Inoperable Tumors
学术与工业合作开发用于不可手术肿瘤的算法不可逆电穿孔的临床工具
- 批准号:
10504276 - 财政年份:2022
- 资助金额:
$ 8.13万 - 项目类别:
Academic-Industrial Partnership to Develop Clinical Tools for Algorithmic Irreversible Electroporation of Inoperable Tumors
学术与工业合作开发用于不可手术肿瘤的算法不可逆电穿孔的临床工具
- 批准号:
10708837 - 财政年份:2022
- 资助金额:
$ 8.13万 - 项目类别:
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
不可逆电穿孔与免疫疗法相结合用于胰腺癌的全身治疗
- 批准号:
10331072 - 财政年份:2021
- 资助金额:
$ 8.13万 - 项目类别:
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
不可逆电穿孔与免疫疗法相结合用于胰腺癌的全身治疗
- 批准号:
10737800 - 财政年份:2021
- 资助金额:
$ 8.13万 - 项目类别:
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
不可逆电穿孔与免疫疗法相结合用于胰腺癌的全身治疗
- 批准号:
10154535 - 财政年份:2021
- 资助金额:
$ 8.13万 - 项目类别:
Alcohol-induced Skeletal Muscle Insulin Insensitivity in SIV/HIV: Myotube-derived Extracellular Vesicle-mediated Mechanisms
SIV/HIV 中酒精诱导的骨骼肌胰岛素不敏感:肌管衍生的细胞外囊泡介导的机制
- 批准号:
10326642 - 财政年份:2021
- 资助金额:
$ 8.13万 - 项目类别:
Combining Irreversible Electroporation with Immunotherapy for the Systemic Treatment of Pancreatic Cancer
不可逆电穿孔与免疫疗法相结合用于胰腺癌的全身治疗
- 批准号:
10577802 - 财政年份:2021
- 资助金额:
$ 8.13万 - 项目类别:
Alcohol-induced Skeletal Muscle Insulin Insensitivity in SIV/HIV: Myotube-derived Extracellular Vesicle-mediated Mechanisms
SIV/HIV 中酒精诱导的骨骼肌胰岛素不敏感:肌管衍生的细胞外囊泡介导的机制
- 批准号:
10554094 - 财政年份:2021
- 资助金额:
$ 8.13万 - 项目类别:
Irreversible electroporation for combinatorial GBM treatment
用于 GBM 组合治疗的不可逆电穿孔
- 批准号:
10220883 - 财政年份:2017
- 资助金额:
$ 8.13万 - 项目类别: